Verseon Showcases Candidates for Next-Generation Diabetic Eye Disease Drugs
Go back to Verseon Showcases Candidates for Next-Generation Diabetic Eye Disease Drugs| (NYSE: VERS) | Delayed: 70.86 -0.01 (0.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $70.87 | 52 Week High | $ | |||
| Open | $70.86 | 52 Week Low | $ | |||
| Day High | $70.86 | P/E | N/A | |||
| Day Low | $70.86 | EPS | $ | |||
| Volume | 24 | |||||
